NCT04776811View on ClinicalTrials.gov

Evaluation of Accuracy of Guardian Sensor 3 in Diabetes Patients on Peritoneal Dialysis

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

September 30, 2022

Study Completion Date

September 30, 2022

Conditions
Diabetes Mellitus (Diagnosis)End Stage Renal DiseaseDialysis
Interventions
DEVICE

Continuous glucose monitoring system

Medtronic Guardian Connect with Guardian Sensor 3

Trial Locations (1)

Unknown

Elaine Chow, Hong Kong

All Listed Sponsors
collaborator

Medtronic Diabetes

INDUSTRY

lead

Elaine Chow

OTHER

NCT04776811 - Evaluation of Accuracy of Guardian Sensor 3 in Diabetes Patients on Peritoneal Dialysis | Biotech Hunter | Biotech Hunter